Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?
- PMID: 18561521
- PMCID: PMC2496969
- DOI: 10.2147/vhrm.s1452
Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?
Abstract
Polycystic ovary syndrome (PCOS), a common reproductive endocrine condition manifests at puberty, and is characterized by hyperandrogenism, chronic anovulation, and obesity. PCOS cases exhibit an adverse coronary heart disease (CHD) profile at an early age, including insulin resistance, dyslipidemia and increased central adiposity. It can be hypothesized that the menopausal transition, whether natural or surgical, may provide an additional "insult", resulting in greater cumulative risk to their vasculature. Coronary artery calcification (CAC), a measure of subclinical atherosclerosis (SCA), was measured by electron beam tomography in 149 PCOS cases and 166 controls (mean age 47.3 and 49.4 respectively). Cases had a higher prevalence of CAC (63.1%) compared to controls (41.0%), (p = 0.037) after adjustment for age and BMI. A total of 22 cases and 39 controls had undergone natural menopause, 12 cases and 26 controls underwent surgical menopause (with biochemical confirmation) and 115 cases and 101 controls reported being currently premenopausal. There was a significant difference in CAC values between cases and controls in all three-menopause categories including pre-menopausal, surgically induced and natural menopause (p < 0.001). Duration since menopause (years) and use of hormone replacement therapy were not different between cases and controls for the two menopause groups. Logistic regression was carried out with CAC (< or = 10 vs > 10) as the dependent variable, and independent variables: PCOS status, current age, BMI, and menopausal status, (pre-menopause, surgical and natural menopause) and selected CHD risk factors. The data indicate that women with PCOS exhibit significantly increased CAC compared to controls after adjustment for age and BMI and menopausal status. PCOS status and fasting glucose were significant risk factors for CAC (p < 0.05). Both natural and surgical menopause were independent risk factors for CAC as well (p < 0.01). HDLT was of borderline significance, p < 0.10. Further follow-up of this cohort will be valuable in determining whether PCOS status continues to affect cardiovascular risk as they undergo the menopausal transition.
Figures



Similar articles
-
Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome.J Clin Endocrinol Metab. 2003 Jun;88(6):2562-8. doi: 10.1210/jc.2003-030334. J Clin Endocrinol Metab. 2003. PMID: 12788855
-
Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome.J Clin Endocrinol Metab. 2004 Nov;89(11):5454-61. doi: 10.1210/jc.2003-032237. J Clin Endocrinol Metab. 2004. PMID: 15531497
-
A Systematic Review and Meta-Analysis of the Association Between Polycystic Ovary Syndrome and Coronary Artery Calcification.J Womens Health (Larchmt). 2022 Jun;31(6):762-771. doi: 10.1089/jwh.2021.0608. Epub 2022 May 16. J Womens Health (Larchmt). 2022. PMID: 35575750 Free PMC article.
-
Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women's study.Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2688-94. doi: 10.1161/ATVBAHA.114.304136. Epub 2014 Oct 30. Arterioscler Thromb Vasc Biol. 2014. PMID: 25359859
-
PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis.Hum Reprod Update. 2023 Nov 2;29(6):741-772. doi: 10.1093/humupd/dmad015. Hum Reprod Update. 2023. PMID: 37353908
Cited by
-
Polycystic ovary syndrome is associated with higher left ventricular mass index: the CARDIA women's study.J Clin Endocrinol Metab. 2012 Dec;97(12):4656-62. doi: 10.1210/jc.2012-1597. Epub 2012 Sep 25. J Clin Endocrinol Metab. 2012. PMID: 23012389 Free PMC article.
-
Predictors of urinary albumin excretion in women with polycystic ovary syndrome.Fertil Steril. 2010 May 1;93(7):2285-90. doi: 10.1016/j.fertnstert.2008.12.120. Epub 2009 Feb 12. Fertil Steril. 2010. PMID: 19217093 Free PMC article.
-
Cardiovascular RiskprofilE - IMaging and gender-specific disOrders (CREw-IMAGO): rationale and design of a multicenter cohort study.BMC Womens Health. 2017 Aug 7;17(1):60. doi: 10.1186/s12905-017-0415-x. BMC Womens Health. 2017. PMID: 28784118 Free PMC article.
-
Ovarian hypertension: polycystic ovary syndrome.Endocrinol Metab Clin North Am. 2011 Jun;40(2):433-49, ix-x. doi: 10.1016/j.ecl.2011.01.009. Endocrinol Metab Clin North Am. 2011. PMID: 21565677 Free PMC article.
-
Complications and challenges associated with polycystic ovary syndrome: current perspectives.Int J Womens Health. 2015 Jul 31;7:745-63. doi: 10.2147/IJWH.S70314. eCollection 2015. Int J Womens Health. 2015. PMID: 26261426 Free PMC article. Review.
References
-
- Allain Cc, Poon LS, Chan CSG, et al. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470–5. - PubMed
-
- Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metabolism. 2004;89:2745–9. - PubMed
-
- Bucolo G, David H. Quantitive determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:476–82. - PubMed
-
- Christian RC, Dumesic DA, Behrenbeck T, et al. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88:2562–8. - PubMed
-
- Cole’s Cross Reference Directory. Allegheny County and Greater Pittsburgh Area 1991–1993. Lincoln, Neb: Cole Publications and Information Services; 1993.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical